NCT03981224View on ClinicalTrials.gov

The Value of Post-radiation Detectable Plasma EBV DNA in High-risk Nasopharyngeal Carcinoma Patients

CompletedOBSERVATIONAL

Enrollment

706

Participants

Timeline

Start Date

May 2, 2012

Primary Completion Date

May 1, 2013

Study Completion Date

May 1, 2013

Conditions

Nasopharyngeal Carcinoma

All Listed Sponsors

lead

Taichung Veterans General Hospital

OTHER

NCT03981224 - The Value of Post-radiation Detectable Plasma EBV DNA in High-risk Nasopharyngeal Carcinoma Patients | Biotech Hunter | Biotech Hunter